SAN FRANCISCO, CA--(Marketwire - May 03, 2012) - Linkage Biosciences, Inc., a molecular diagnostics company and leader in molecular HLA typing and associated products, has entered a long-term lease arrangement for new manufacturing, lab, and office space in South San Francisco, California. In the heart of the biotechnology corridor in the Bay Area, this facility will become the primary commercial-scale plant for the company's complete LinkSēq™ product line. The move allows Linkage to continue its growth and expansion in both domestic and international markets.
"This state-of-the-art facility meets our process requirements and provides significantly more production capacity than our previous facility," said Zachary Antovich, CEO of Linkage Biosciences. "In addition, these new facilities accommodate our expanding R&D, regulatory and administrative needs. This facility is ready to be a part of our ISO 13485 certification and other regulatory efforts including CE and FDA regulatory filings."
About Linkages Biosciences
Linkage Biosciences, Inc. is a privately held molecular diagnostics company developing and marketing products that dramatically improve and expedite complex genetic testing. LinkSēq, the company's HLA testing product line, is used in solid organ and stem cell transplantation. To learn more please visit www.linkagebio.com.
Copyright 2012.Linkage Biosciences, Inc. All rights reserved.
Linkage Biosciences and LinkSēq are trademarks of Linkage Biosciences, Inc.